Clinical Trial Update: An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia [Phase 4]

View source ↗

Summary

An open-label Phase 4 trial evaluating the safety and efficacy of chloral hydrate in adults with severe or chronic insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Chloral Hydrate (chloral hydrate)

Snippet

Sponsor: Pharmanovia | Conditions: Insomnia, Insomnia Chronic | Phase 4 | Status: COMPLETED